ClinicalTrials.govpublic full text
Biological Activity and Safety of Low Dose IL2 in Relapsing Remitting Multiple Sclerosis
relapsing remitting multiple sclerosis, interleukin 2, il2, autoimmune diseases, regulatory t cells, tregs, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 915807
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.